CARSGEN THERAPEUTICS HLDGS LTD
(HKEX: 2171)
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The firm focuses on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company was founded by Zong Hai Li and Hua Mao Wang on February 9, 2018, and is headquartered in Shanghai, China.
22.960 -
+0.320
(+1.41%)
Range
22.600 - 24.600
(8.85%)
Open
23.040
Previous Close
22.640
Bid Price
22.960
Bid Volume
('000)
6
Ask Price
22.980
Ask Volume
('000)
10
Volume
('000)
7,636
Value
180,696,984
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
